Stanford, CA, United States of America

Stephen C DeRosa

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Stanford, CA (US) (1992)
  • Menlo Park, CA (US) (1993)

Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Stephen C DeRosa

Introduction

Stephen C DeRosa is a notable inventor based in Stanford, CA. He has made significant contributions to the field of cardiovascular therapy, holding 2 patents that focus on innovative dosage forms for administering nicardipine, a calcium antagonist.

Latest Patents

His latest patents include a dosage form comprising nicardipine and its pharmaceutically acceptable salts for administering to patients in need of cardiovascular therapy. Another patent details a similar dosage form specifically designed for the administration of calcium antagonist nicardipine.

Career Highlights

Stephen C DeRosa is associated with Alza Corporation, where he has been instrumental in developing therapeutic solutions. His work has had a profound impact on the treatment of cardiovascular conditions.

Collaborations

Some of his notable coworkers include Joseph C Deters and David R Swanson, who have collaborated with him on various projects.

Conclusion

Stephen C DeRosa's contributions to cardiovascular therapy through his innovative patents highlight his role as a significant figure in the field of medical inventions. His work continues to influence the development of effective treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…